Tyra Biosciences, Inc. (TYRA) Financials

TYRA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 412.0 million 24.5 million
Dec. 31, 2025 282.6 million 23.4 million
Sept. 30, 2025 301.9 million 21.3 million
June 30, 2025 321.5 million 19.4 million

TYRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -32.7 million 7.8 million
Dec. 31, 2025 -23.7 million 7.6 million
Sept. 30, 2025 -22.4 million 7.6 million
June 30, 2025 -23.7 million 6.4 million

TYRA Net Income

No data available :(

TYRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 383.5 million 5.2 million 5.7 million
Dec. 31, 2025 256.0 million 5.3 million 5.8 million
Sept. 30, 2025 274.9 million - 5.5 million
June 30, 2025 296.3 million - 6.0 million

TYRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 61.7 million
Dec. 31, 2025 59.6 million
Sept. 30, 2025 59.7 million
June 30, 2025 59.6 million

TYRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 88000 33.3 million 8.5 million -
Dec. 31, 2025 57000 28.2 million 8.3 million -
Sept. 30, 2025 39000 25.5 million 7.5 million -
June 30, 2025 31000 24.3 million 7.1 million -

TYRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 138000
Dec. 31, 2025 - 132000
Sept. 30, 2025 - -
June 30, 2025 - 140000

TYRA

Price: $28.55

52 week price:
8.98
40.65

Earnings Per Share: -2.18 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1674

Market Capitalization: 1.6 billion

Links: